» Articles » PMID: 32032351

SmartPhase: Accurate and Fast Phasing of Heterozygous Variant Pairs for Genetic Diagnosis of Rare Diseases

Overview
Specialty Biology
Date 2020 Feb 8
PMID 32032351
Citations 7
Authors
Affiliations
Soon will be listed here.
Abstract

There is an increasing need to use genome and transcriptome sequencing to genetically diagnose patients suffering from suspected monogenic rare diseases. The proper detection of compound heterozygous variant combinations as disease-causing candidates is a challenge in diagnostic workflows as haplotype information is lost by currently used next-generation sequencing technologies. Consequently, computational tools are required to phase, or resolve the haplotype of, the high number of heterozygous variants in the exome or genome of each patient. Here we present SmartPhase, a phasing tool designed to efficiently reduce the set of potential compound heterozygous variant pairs in genetic diagnoses pipelines. The phasing algorithm of SmartPhase creates haplotypes using both parental genotype information and reads generated by DNA or RNA sequencing and is thus well suited to resolve the phase of rare variants. To inform the user about the reliability of a phasing prediction, it computes a confidence score which is essential to select error-free predictions. It incorporates existing haplotype information and applies logical rules to determine variants that can be excluded as causing a recessive, monogenic disease. SmartPhase can phase either all possible variant pairs in predefined genetic loci or preselected variant pairs of interest, thus keeping the focus on clinically relevant results. We compared SmartPhase to WhatsHap, one of the leading comparable phasing tools, using simulated data and a real clinical cohort of 921 patients. On both data sets, SmartPhase generated error-free predictions using our derived confidence score threshold. It outperformed WhatsHap with regard to the percentage of resolved pairs when parental genotype information is available. On the cohort data, SmartPhase enabled on average the exclusion of approximately 22% of the input variant pairs in each singleton patient and 44% in each trio patient. SmartPhase is implemented as an open-source Java tool and freely available at http://ibis.helmholtz-muenchen.de/smartphase/.

Citing Articles

Comprehensive mutational profiling identifies new driver events in cutaneous leiomyosarcoma.

van der Weyden L, Del Castillo Velasco-Herrera M, Cheema S, Wong K, Boccacino J, Offord V Br J Dermatol. 2024; 192(2):335-343.

PMID: 39392932 PMC: 11758588. DOI: 10.1093/bjd/ljae386.


Induced and natural variation affect traits independently in hybrid Populus.

Guo W, Bastiaanse H, Maloof J, Comai L, Henry I G3 (Bethesda). 2024; 14(11).

PMID: 39268720 PMC: 11540314. DOI: 10.1093/g3journal/jkae218.


cLD: Rare-variant linkage disequilibrium between genomic regions identifies novel genomic interactions.

Wang D, Perera D, He J, Cao C, Kossinna P, Li Q PLoS Genet. 2023; 19(12):e1011074.

PMID: 38109434 PMC: 10758262. DOI: 10.1371/journal.pgen.1011074.


Inferring compound heterozygosity from large-scale exome sequencing data.

Guo M, Francioli L, Stenton S, Goodrich J, Watts N, Singer-Berk M Nat Genet. 2023; 56(1):152-161.

PMID: 38057443 PMC: 10872287. DOI: 10.1038/s41588-023-01608-3.


Familial co-segregation and the emerging role of long-read sequencing to re-classify variants of uncertain significance in inherited retinal diseases.

Gupta P, Nakamichi K, Bonnell A, Yanagihara R, Radulovich N, Hisama F NPJ Genom Med. 2023; 8(1):20.

PMID: 37558662 PMC: 10412581. DOI: 10.1038/s41525-023-00366-9.


References
1.
Ng S, Nickerson D, Bamshad M, Shendure J . Massively parallel sequencing and rare disease. Hum Mol Genet. 2010; 19(R2):R119-24. PMC: 2953741. DOI: 10.1093/hmg/ddq390. View

2.
Hastreiter M, Jeske T, Hoser J, Kluge M, Ahomaa K, Friedl M . KNIME4NGS: a comprehensive toolbox for next generation sequencing analysis. Bioinformatics. 2017; 33(10):1565-1567. DOI: 10.1093/bioinformatics/btx003. View

3.
Wright C, Fitzpatrick D, Firth H . Paediatric genomics: diagnosing rare disease in children. Nat Rev Genet. 2018; 19(5):253-268. DOI: 10.1038/nrg.2017.116. View

4.
Choi Y, Chan A, Kirkness E, Telenti A, Schork N . Comparison of phasing strategies for whole human genomes. PLoS Genet. 2018; 14(4):e1007308. PMC: 5903673. DOI: 10.1371/journal.pgen.1007308. View

5.
Castel S, Mohammadi P, Chung W, Shen Y, Lappalainen T . Rare variant phasing and haplotypic expression from RNA sequencing with phASER. Nat Commun. 2016; 7:12817. PMC: 5025529. DOI: 10.1038/ncomms12817. View